Clinical trials
Cancer (With or Without Metastasis) clinical trials
Below are recruiting cancer (with or without metastasis) clinical trials, each written for real people, not researchers. We’re tracking 13,102 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06223295Recruiting
Focal therapy for medium-risk prostate cancer
This trial tests a gentler treatment called focal therapy that targets only the part of the prostate with cancer. It's for men whose prostate cancer has a Gleason score of 7, low PSA, and hasn't spread outside the prostate.
Nijmegen, GelderlandAges 45 years+ - NCT06266026Recruiting
AI-enhanced thermal imaging for breast cancer screening
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
HeidelbergAges 18 years+ - NCT05965024Recruiting
Using ctDNA blood tests to predict lung cancer return after surgery
This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06270017RecruitingPhase 1/Phase 2
Zebrafish Avatars for Colon Cancer Treatment
This trial uses tiny zebrafish to grow a piece of your tumor and test which treatments might work best for you. It is for patients with colon cancer who are scheduled for surgery to remove their tumor.
Linköping, Östergötland CountyAges 18 years+ - NCT07870577Recruiting
Nerve health during bladder cancer treatment
This study looks at nerve problems (peripheral neuropathy) in people with muscle-invasive bladder cancer who receive a combination of two drugs, enfortumab vedotin and pembrolizumab, before or after surgery. The goal is to understand how these treatments affect nerves and to help manage side effects.
Munich, BavariaAges 18 years+ - NCT07860528Recruiting
High-dose brachytherapy for prostate cancer that has returned
This trial tests a type of radiation therapy called high-dose-rate brachytherapy, which is given to men whose prostate cancer has come back after their first treatment. It aims to control the cancer while keeping side effects low.
Benidorm, AlicanteAges 18 years+ - NCT07855627Recruiting
Predicting lymphedema risk before surgery
This study looks at whether a simple measurement taken before surgery can help predict if you might develop lymphedema (arm swelling) after treatment. It is for women with newly diagnosed inflammatory breast cancer who are planning to have standard treatments.
Houston, TexasAges 18 years+ - NCT06151262RecruitingPhase 2
Trilaciclib plus mFOLFIRINOX for advanced pancreatic cancer
This trial tests a new drug, trilaciclib, combined with a standard chemotherapy regimen (mFOLFIRINOX) for people with advanced pancreatic cancer who have not yet had treatment. The goal is to see if adding trilaciclib can help reduce side effects and improve how well the treatment works.
Nanjing, JiangsuAges 18–75 - NCT06270043Recruiting
Focal therapy study for early-stage prostate cancer
This study is tracking men who choose focal therapy (a targeted treatment) for their localized prostate cancer. It aims to learn how well this treatment works and how it affects quality of life.
La Jolla, CaliforniaAges 18 years+ - NCT06230445RecruitingPhase 3
Digital health app for lung cancer management
This trial tests a digital health app to help manage the entire treatment process for lung cancer. It may assist patients who are already undergoing or have completed treatments like surgery or chemotherapy.
Guangzhou, GuangdongAges 18–70 - NCT01935778RecruitingPhase 3
Extra chemo after stomach cancer surgery: compare two drug plans
This Phase 3 trial tests which combination of chemotherapy works better after surgery for stage IIIB/IV stomach or stomach–esophagus junction adenocarcinoma. Participants get randomized to one of two chemotherapy plans to see which helps people live longer and/or prevents cancer from coming back.
SeoulAges 20–75 - NCT06278870RecruitingPhase 3
New drug combo vs standard for HER2+ advanced breast cancer
This trial compares two drug combinations for HER2-positive breast cancer that has spread. It tests a newer drug (Disitamab Vedotin + Pyrotinib) against a standard treatment (THP) as a first treatment option.
Guangzhou, GuangdongAges 18–75 - NCT02454790Recruiting
Follow-up program for people with esophageal cancer
This trial tests a standard follow-up plan for people who have esophageal cancer and received a certain amount of radiation. It may help your care team monitor side effects and catch health changes early.
GroningenAges 18 years+ - NCT02733289Recruiting
Follow-up program for women treated for cervical cancer
This trial studies a standard follow-up plan for people who are treated with radiation with the goal of cure for cervical cancer. It may help your care team monitor recovery, side effects, and overall health over time.
GroningenAges Any age - NCT05505357Recruiting
Skip breast surgery after excellent MRI response
This trial tests whether some women with HER2-positive breast cancer can safely avoid breast surgery if their tumor nearly disappears after chemotherapy. It uses MRI and biopsy results to find people most likely to have no remaining cancer (pCR).
SeoulAges 20 years+ - NCT07872956Recruiting
Yoga app for home cancer rehab
This trial studies a yoga app designed with patient input to help people undergoing cancer treatment exercise at home. It aims to see if the app is practical and helpful for improving well-being during cancer care.
LinköpingAges 18 years+ - NCT06206083Recruiting
Studying endometrial cancer types to predict outcomes
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
Mexico City, Mexico CityAges 18 years+ - NCT06155396RecruitingPhase 2
Targeted drug combo for advanced cervical cancer
This trial tests a combination of two drugs: an antibody-drug conjugate (RC48-ADC) that targets HER2 on cancer cells, plus an immunotherapy (Zimberelimab) that helps your immune system attack the cancer. It is for people with advanced cervical cancer whose prior platinum-based chemotherapy has stopped working.
Bengbu, AnhuiAges 18 years+ - NCT07854600RecruitingPhase 2
Ivonescimab plus chemotherapy before surgery for bile duct cancer
This trial tests a new drug combination given before surgery to shrink bile duct cancer tumors, potentially making surgery more successful. It is for patients whose cancer is locally advanced or has spread to only a few places.
Beijing, Beijing MunicipalityAges 18–80 - NCT07857655RecruitingPhase 4
Intraoperative methadone for pain after head and neck cancer surgery
This trial tests whether giving methadone during your head and neck cancer surgery helps control pain right after the operation. Methadone is a long-acting painkiller that might reduce pain for up to a day or more, potentially improving your recovery experience.
Portland, OregonAges 18–89 - NCT07858630Recruiting
Radiation targeting for advanced esophageal cancer with immunotherapy
This trial studies how to best target radiation for people with advanced esophageal cancer who are also getting immunotherapy. It aims to improve treatment planning to help patients live longer with fewer side effects.
Beijing, Beijing MunicipalityAges 18–80 - NCT06284070Recruiting
Comparing FDG and FAPI PET scans for cancer
This study compares two types of PET scans (FDG and FAPI) in people with suspected or newly diagnosed cancer. It aims to learn which scan gives better images of different cancers, potentially helping guide treatment decisions.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06284031Recruiting
Cervical cancer brachytherapy with needles in 3 sessions
This trial tests a special type of radiation, called brachytherapy, given in 3 sessions using thin needles. It is for people with cervical cancer that has not spread too far, and who have already had standard radiation treatment.
SingaporeAges 21 years+ - NCT06282796Recruiting
Early heart risk monitoring for breast cancer chemo
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
Fuzhou, FujianAges 18–80
Hear when a new Cancer (With or Without Metastasis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer (with or without metastasis)?
- Yes. Clin2 currently lists 13,102 recruiting cancer (with or without metastasis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer (with or without metastasis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer (with or without metastasis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Non Small Cell Lung Cancer
- Liver Metastasis Colon Cancer
- Gastric Cancer, Gastroesophageal Junction Cancer
- Lung Cancer Non-Small Cell Cancer (NSCLC)
- Colorectal Cancer Liver Metastasis
- Breast Cancer (Triple Negative Breast Cancer (TNBC))
- Leptomeningeal Metastasis of Breast Cancer
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.